NORTHERN TRUST CORP
BankPosition in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 73124
CHICAGO, IL
Position in MRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,242,244
+$3,098,359 QoQ
Shares Held
1,000,360
-10.0% QoQ
Ownership
0.385%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 177 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. MRVI ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,242,244 | 1,000,360 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,143,885 | 1,110,914 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,862,797 | 880,861 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,659,590 | 926,687 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,398,683 | 995,305 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,407,700 | 1,089,458 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,833,814 | 1,070,425 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $8,450,861 | 1,016,951 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $6,641,299 | 927,556 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $8,247,873 | 951,312 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,196,180 | 945,982 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,902,040 | 990,204 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,030,853 | 565,636 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,500,625 | 820,887 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,409,018 | 797,276 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,306,770 | 521,221 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,222,836 | 465,429 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,176,734 | 487,007 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $20,401,778 | 486,916 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $22,973,168 | 468,076 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $29,435,756 | 705,386 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,331,297 | 345,996 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||